Glyburide
Product Images NDC 42254-281

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glyburide (NDC 42254-281). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glyburide Structural Formula (Aadcb1a8 2605 40b3 A652 2787ec833278 01)

Chemical structure diagram of the active ingredient Glyburide illustrating its molecular composition and connectivity, including aromatic rings, chlorine and methoxy substituents, and sulfonylurea groups.*

FDA Label Image

Figure A: Single-dose Bioavailability Study (Aadcb1a8 2605 40b3 A652 2787ec833278 02)

A line graph depicting the concentration of glyburide in ng/mL over a 24-hour period. It compares the concentration profiles of Glyburide Tablets (micronized) 3 mg and Nonmicronized Glyburide Tablets 5 mg, showing changes in drug concentration with time.*

FDA Label Image

Glyburide 6mg (Aadcb1a8 2605 40b3 A652 2787ec833278 03)

Label for Glyburide 6mg micronized tablets by Physician Partner, a division of Rebel Distributors Corp. The label indicates a 90-count package with NDC 42254-281-90. Tablets are described as dark-blue, oval-shaped, flat face, with engravings '6 / 036' and a stylized 'N'. Manufacturer is Teva Canada Limited, Toronto.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.